Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

601results about How to "Strong inhibitory activity" patented technology

Tryptamine compound as well as preparation method and application thereof

The invention discloses a tryptamine compound as well as a preparation method and application thereof. The tryptamine compound can be used for preparing medicines for preventing and / or treating cancers. The cancer is at least one of breast cancer, liver cancer, lung cancer, colorectal cancer, leukemia, pancreatic cancer, glioma, osteosarcoma, cervical cancer, ovarian cancer, kidney cancer and esophageal cancer. According to the invention, activity screening is carried out on a plurality of compounds, the three tryptamine compounds provided by the invention are found to have excellent inhibitory activity on a plurality of different types of human cancer cells for the first time, and an optional scheme is provided for broad-spectrum anti-cancer drugs.
Owner:KUNMING MEDICAL UNIVERSITY

Preparation method of codfish skin collagen peptide with high ACE (Angiotensin Converting Enzyme) inhibitory activity

The invention discloses a preparation method of cod skin collagen peptide with high ACE (angiotensin converting enzyme) inhibitory activity, which comprises the following steps: firstly, scaling cod skin, cleaning, cutting into small pieces, pretreating with NaOH and n-butyl alcohol to remove impure protein and certain lipid substances, preparing cod skin gelatin by a hot water extraction method, and then adding the cod skin gelatin into the cod skin collagen peptide to obtain cod skin collagen peptide; the cod skin collagen peptide with high ACE inhibitory activity is prepared by using cod skin collagen as a raw material, performing enzymolysis on the cod skin collagen peptide sequentially by using a double-enzyme distribution enzymolysis method, performing enzyme deactivation and centrifugal treatment after enzymolysis, and performing membrane separation on enzymolysis supernate. The whole enzymolysis process is more thorough by adopting a double-enzyme distribution enzymolysis method, more small molecule peptides can be obtained, cod skin collagen peptide with high ACE inhibitory activity can be further enriched by combining a membrane separation method, the utilization degree of cod skin resources is effectively improved, and the cod skin collagen peptide has a relatively wide application prospect.
Owner:JIANGSU OCEAN UNIV

Sesquiterpenoids as well as preparation method and application thereof

The invention discloses sesquiterpenoids as well as a preparation method and application thereof. The structure of the sesquiterpenoids is shown in the specification. The sesquiterpenoids of # imgabs0 can be used for preparing drugs for preventing and / or treating cancers, and the cancers comprise at least one of breast cancer, liver cancer, lung cancer, colorectal cancer, leukemia, pancreatic cancer, glioma, osteosarcoma, cervical cancer, kidney cancer and skin cancer. According to the invention, various natural product extracts are subjected to activity screening, the sesquiterpenoids derived from the rattan chrysanthemum have excellent inhibitory activity on various different types of human cancer cells, and an optional scheme is provided for broad-spectrum anti-cancer drugs. The sesquiterpenoids applied in the invention are derived from rattan chrysanthemum, the source is wide, and the production cost is low.
Owner:GUIZHOU MEDICAL UNIV +1

Phyllanthus emblica fermentation liquor and preparation method thereof

The invention relates to the technical field of deep processing of phyllanthus emblica, in particular to phyllanthus emblica fermentation liquor and a preparation method thereof. The preparation method comprises the following steps: uniformly mixing crushed phyllanthus emblica pulp with water; after sterilization, adding lactic acid bacteria mixed powder for fermentation treatment; cellulase is added into the fermentation liquor for hydrolysis, and hydrolysate is obtained after enzyme deactivation; the hydrolysate is subjected to extraction treatment and solid-liquid separation, and the phyllanthus emblica fermentation liquor is obtained. By adopting the method disclosed by the invention, 107.11 mg of gallic acid, 360.76 mg of polyphenol and 65.56 mg of flavone can be extracted from each gram of the phyllanthus emblica raw material respectively, and the contents of gallic acid, polyphenol and flavone are increased by about 2.1 times, 4.5 times and 1.7 times respectively compared with those of gallic acid, polyphenol and flavone which are not subjected to fermentation treatment; the phyllanthus emblica fermentation liquor has alpha-glucosidase inhibitory activity, xanthine oxidase inhibitory activity, pancreatic lipase inhibitory activity, tyrosinase inhibitory activity and antioxidant activity; the phyllanthus emblica fermentation liquor is good in taste and flavor, and has the functions of reducing blood sugar, blood fat and uric acid and resisting oxidation.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Walnut meal-derived antibacterial polypeptide and application thereof

The invention discloses a walnut meal-derived antibacterial polypeptide and application thereof, and belongs to the technical field of biology. The amino acid sequence of the walnut meal-derived antibacterial polypeptide disclosed by the invention is shown as any one of SEQ ID NO.1-3. The walnut meal is adopted as the raw material, the antibacterial polypeptide is extracted and separated, the utilization rate of the walnut meal can be effectively increased, resource waste is reduced, a new polypeptide variety is provided for the antibacterial polypeptide field, and new resources are provided for development of novel antibacterial agents, bacterial lysis solutions, food preservatives and anti-infection drugs.
Owner:YANCHENG INST OF TECH

Trichilin type limonin compound as well as extraction and separation method and application thereof

The invention discloses a Trichilin type limonin compound as well as an extraction and separation method and application of the Trichilin type limonin compound. According to the present invention, the Trichilin type limonin compounds, such as Trichilin G, Trichilin H, 12-hydroxyacetorapatin, azedarach B and 12-O-deacetyltririchilin H, are extracted and separated from the partridge flower and leaf so as to obtain the Trichilin type limonin compounds, wherein the Trichilin type limonin compounds comprise the following components: Trichilin G, Trichilin H, 12-hydroxyacetorapatin, azedarach B and 12-O-deacetyltririchilin H. According to the present invention, the limonin compound obtained through separation has strong inhibition activity on human colon cancer cells (HCT-116), human lung adenocarcinoma cells (NCl-H1975) and human neuroblastoma cells (SH-SY5Y), and provides an optional scheme for broad-spectrum anti-cancer drugs. The limonin compound applied in the invention is derived from a natural plant mallotus oblongifolius, is wide in source and low in production cost, and has good value and application prospect in the aspect of preparing antitumor drugs.
Owner:GUIZHOU MEDICAL UNIV +1

Application of Peniazathilone A as alpha-glucosidase inhibitor and preparation method of Peniazathilone A

The name of the invention is application of Peniazathilone A as an alpha-glucosidase inhibitor and a preparation method of the Peniazathilone A. The invention belongs to the technical field of medicines, and relates to application of an azone compound as the alpha-glucosidase inhibitor. The compound has the following structure: # imgabs0 #. The compound Peniazathilone A is obtained by extracting, separating and purifying an ethyl acetate extract phase of a fermented product of Penicillium sp from soil, and the alpha-glucosidase inhibition activity of the compound is evaluated by adopting a pNPG method. Experimental results show that the IC50 value of the compound Peniazathilone A is 86.8 [mu] M (the IC50 value of a positive control acarbose is 5.97 mM), and the inhibition rate reaches 92.4% when the concentration of the compound is 0.466 mM. The compound has obvious activity of inhibiting alpha-glucosidase, is expected to be developed into a novel hypoglycemic drug, and has potential medical and health-care values.
Owner:YIBIN UNIV

Trichoderma asperellum TAZ19, biocontrol inoculant and application of Trichoderma asperellum TAZ19

The invention provides a Trichoderma asperellum TAZ19, a biocontrol inoculant and application of the Trichoderma asperellum TAZ19, the Trichoderma asperellum TAZ19 is preserved in the China Center for Type Culture Collection on October 25, 2024, and the preservation number of the Trichoderma asperellum TAZ19 is CCTCC M 20242341. The active ingredients of the biocontrol inoculant comprise the trichoderma asperellum TAZ19 strain, and the trichoderma asperellum TAZ19 strain is one or more of conidia, hypha, fermentation filtrate or active extracts of the trichoderma asperellum TAZ19 strain of the trichoderma asperellum TAZ19 strain. The trichoderma asperellum TAZ19 has an excellent antagonistic effect on a plurality of plant disease pathogenic bacteria such as dispora pinnatifida, a plurality of fusarium oxysporum, apple black beancurd skin fungi and botryosphaeria dothidea, has broad-spectrum antibacterial activity, is high in growth speed, high in antibacterial activity and high in hyperparasitism ability, has better saline-alkaline tolerance, also has a growth promoting effect on plants, and can be widely applied to the field of plant diseases. The strain can be used as an active component of a biocontrol inoculant to be widely applied to prevention and treatment of various plant diseases such as pine tree branch rot, wheat stem rot and tomato fusarium wilt, and has a wide application prospect.
Owner:QINGDAO AGRI UNIV

Complement factor B inhibitor as well as medicinal composition and application thereof

The invention provides a complement factor B inhibitor compound, pharmaceutically acceptable salts thereof, a medicinal composition thereof and application of the complement factor B inhibitor compound in preparation of medicines related to complement factor B. The compound has a structural formula shown in a formula (I), and experimental results show that the compound has good complement factor B inhibitory activity, good in-vivo C3a level inhibition rate, bioavailability and safety. Particularly, the polypeptide has more remarkable binding capacity with target protein. # imgabs0 #
Owner:HINYE PHARM CO LTD

Application of phenolic compound and / or pharmaceutically acceptable salt thereof in preparation of medicine for treating breast cancer, and pharmaceutical composition

The invention provides application of a phenolic compound and / or pharmaceutically acceptable salt thereof in preparation of a medicine for treating breast cancer and a pharmaceutical composition, and relates to the technical field of biological medicines. The invention discloses application of phenolic compounds and / or pharmaceutically acceptable salts thereof in preparation of medicines for treating breast cancer. The phenolic compounds comprise a compound 1 and / or a compound 2. The compound 1 (arnebidin) and the compound 2 ((+)-(R)-de-O-metalasiodiplodin) adopted in the invention have good inhibition effects on human triple-negative breast cancer MDA-MB-231 cell strains, the IC50 value of the compound 1 is 1.16 [mu] M, and the IC50 value of the compound 2 is 0.68 [mu] M, so that a new choice is provided for developing drugs for treating triple-negative breast cancer, and the compound 1 and the compound 2 have good application prospects. The compound has a good application prospect in preparation of medicines for treating breast cancer, especially medicines for treating triple-negative breast cancer.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Fatty acylation BimBH3 analogue containing D-type amino acid as well as preparation method and application of fatty acylation BimBH3 analogue

The invention discloses a BimBH3 analogue containing D-type amino acid and N-terminal fatty acid acylation, a preparation method of the BimBH3 analogue and application of the BimBH3 analogue as a PTPN1 inhibitor to development of hypoglycemic drugs. The structural general formula of the novel BimBH3 mimic peptide analogue is shown as a formula I: # imgabs0 #, wherein Raa2 is equal to D-His, D-Leu, D-Pro, D-Ser, D-Arg, D-Gln, D-Lys, D-Trp, D-Val, D-Tyr, D-Ala, Raa3 is equal to D-Gln, Raa7 is equal to D-Arg, and Raa8 is equal to D-Allo-Ile. The mimic peptide compound is derived from a core region of a Bim-BH3 structural domain, different D-type amino acid site-specific replacement modification and N-terminal conjugated hexadecanoic acid modification are adopted for amino acids at the second, third, seventh and eighth sites respectively, the BimBH3 mimic peptide modified by the D-type amino acid is more stable and has higher metabolic stability, and the target binding capacity and inhibitory activity of the BimBH3 mimic peptide can still be reserved or even improved. The BimBH3 mimic peptide compound shows an excellent PTPN1 inhibitor, the ability of resisting protease hydrolase and various digestive enzymes is also remarkably improved, and the BimBH3 mimic peptide compound has longer pharmacological action time and can play a potential long-acting hypoglycemic role through subcutaneous injection or oral administration. The compound is completely prepared by a polypeptide solid-phase synthesis method, and an obtained crude product is subjected to semi-preparative liquid chromatography purification and freeze-drying to obtain a target compound.
Owner:QINGDAO UNIV OF SCI & TECH

Aromatic fused ring compound, pharmaceutical composition containing aromatic fused ring compound and application of aromatic fused ring compound

The invention provides an aromatic fused ring compound, a pharmaceutical composition containing the compound and application of the aromatic fused ring compound, and relates to the technical field of medicines. The aromatic fused ring compound disclosed by the invention has a structure as shown in a formula (I): # imgabs0 # or a stereoisomer and pharmaceutically acceptable salt thereof, wherein the structural unit # imgabs1 # is selected from # imgabs2 # or # imgabs3 #, and each substituent group is defined in the specification. The aromatic fused ring compound has a strong inhibition effect on SIKs enzyme activity, has a positive regulation effect on TNF-alpha and IL-10 in serum of mice with acute inflammation, has a longer half-life period and a higher oral exposure amount, has a remarkable inhibition effect on NF-kappa B gene expression of THP-1 cells under MDP stimulation, and can be used for preparing medicines for treating acute inflammation. The traditional Chinese medicine composition has a remarkable weight recovery promoting effect on cachexia induced by cis-platinum.
Owner:HANG ZHOU YUHONG PHARMATECH CO LTD

Tobacco and waltheria indica intercropping method

The invention provides an intercropping method of tobacco and waltheria indica. The intercropping method comprises the following steps that 1, before tobacco and waltheria indica are planted, soil is deeply ploughed, a composite agent is sprayed, and then base fertilizer is applied; the composite agent is prepared from the following raw materials: ammonium sulfate, tea tree oil, rhizobium and a peanut vine extract; (2) tobacco seedlings are selected and transplanted in February to March, waltheria indica is planted between rows, and after planting is conducted for 2-3 weeks, compound fertilizer is applied between the rows of the tobacco seedlings and the waltheria indica; (3) when rainstorm weather occurs, spraying a complex microbial inoculant within 24 hours after rainstorm, and (4) managing until harvesting tobacco and waltheria indica. By the adoption of the intercropping method, nematodes in soil are inhibited, the tobacco and the waltheria indica are effectively improved, symbiosis and growth of the tobacco and the waltheria indica are promoted, and the harvesting yield per mu of the tobacco and the waltheria indica is increased.
Owner:HAINAN TOBACCO CO DANZHOU CO

Substituted oxadiazole-aniline compound and application thereof

The invention belongs to the technical field of medicines, and discloses a substituted oxadiazole-aniline compound, a preparation method thereof, a pharmaceutical composition taking the compound as an active component, and application of the substituted oxadiazole-aniline compound and the pharmaceutical composition in treatment and / or prevention of infectious diseases caused by coronavirus. Specifically, the invention relates to a compound shown as a formula (I) and an isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the compound disclosed by the invention, and R1, R2, R3, R4 and n are described in the specification. The invention aims to prepare a new compound with anti-coronavirus activity, and the new compound can be used as a potential new drug for treatment or prophylactic treatment of infectious diseases caused by viruses, especially pneumonia diseases caused by coronaviruses. # imgabs0 #
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI +1

Environment-friendly hydrate compound inhibitor as well as preparation method and application thereof

The invention discloses an environment-friendly hydrate compound inhibitor as well as a preparation method and application thereof, and relates to the technical field of hydrates. The compound inhibitor is prepared from potassium acetate serving as a main inhibitor, glycine serving as an auxiliary agent and water, can synergistically achieve the inhibition effect on hydrate generation in the two aspects of thermodynamics and dynamics, and has a good inhibition effect on hydrate formation and blocking. Meanwhile, the compound inhibitor has the characteristics of low use cost, no toxicity, no corrosion and environmental friendliness, has wide application prospects in the field of oil and gas transportation, and is easy to popularize and use.
Owner:JILIN UNIVERSITY

Coumarin tyramine glycoside compound and application thereof in preparation of PTP1B (protein tyrosine phosphatase 1B) inhibitor and antidiabetic drug

The invention discloses a coumarin tyramine glycoside compound and application thereof in preparation of PTP1B (protein tyrosine phosphatase 1B) inhibitors and antidiabetic drugs. The structural formula of the compound is # imgabs0 #, in the formula, R represents fat (aromatic) acyl or monosaccharide substituent, and R'represents hydrogen atom or acetyl; 4-methoxycoumarin 4 '-acetyl-O-L-rhamnose is used as an initial raw material, fat (aromatic) acyl or monosaccharide substituent groups are introduced into hydroxyl at the second position and hydroxyl at the third position of L-rhamnose at the same time, and then protecting groups of glycosyl are removed, so that the L-rhamnose is prepared. Pharmacological activity tests show that the compounds have good inhibitory activity on protein tyrosine phosphatase 1B, which indicates that the coumarin tyramine glycoside compounds can be researched and utilized as novel PTP1B inhibitors and antidiabetic drugs.
Owner:NORTHWEST UNIV

Application of B-AP15 in preparation of antituberculous drugs

The invention provides application of B-AP15 in preparation of antituberculosis drugs, and particularly belongs to the technical field of drug preparation. The B-AP15 is used for preparing the antituberculous drugs and has relatively good inhibitory activity on MTB standard strains, MTB sensitive strains and clinical drug-resistant strains, so that a drug lead compound and a drug candidate are provided for development of the novel antituberculous drugs, and the B-AP15 has important significance on prevention and / or treatment of tuberculosis.
Owner:MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI

Compound containing synene fragment, application of compound, pesticide for preventing and controlling nematodes and fungi, and method for preventing and controlling nematodes and fungi

The invention relates to the field of novel pesticide compounds, and discloses a compound containing a synene fragment and application thereof, a pesticide for preventing and controlling nematodes and / or fungi, and a method for preventing and controlling nematodes and / or fungi. The compound has a structure as shown in a formula (I). The compound containing the synene fragment, provided by the invention, has excellent biological activity on at least one plant parasitic nematode and / or fungus included in the synene fragment at a low dosage. # imgabs0 #
Owner:JIANGSU FLAG CHEM IND CO LTD

Aryl piperidine compound as well as preparation method, pharmaceutical composition and application thereof

The invention discloses an aryl piperidine compound as well as a preparation method, a pharmaceutical composition and application thereof. The structure of the compound is shown in a formula (I), the compound further comprises an isomer, a prodrug, a stable isotope derivative, pharmaceutically acceptable salt or a mixture of the isomer, the prodrug, the stable isotope derivative and the pharmaceutically acceptable salt, and the compound has a remarkable PRMT5 enzyme inhibition effect and is higher in inhibition activity in the presence of MTA; meanwhile, the inhibitory activity on MTAP-deficient tumor cells is higher than that of a wild type, and selectivity is achieved; the compound has good activity at the molecular level and the cellular level and is wide in application; the preparation method is high in universality and easy for compound structure expansion. # imgabs0 #
Owner:CHINA PHARM UNIV

Exonucleotide pyrophosphatase / phosphodiesterase 1 inhibitor as well as preparation method and application thereof

The invention relates to an exonucleotide pyrophosphatase / phosphodiesterase 1 inhibitor as well as a preparation method and application thereof. Specifically, the compound disclosed by the invention has a structure as shown in a formula I, and the definitions of all groups and substituent groups are described in the specification. The invention also discloses a preparation method of the compound and application of the compound in preventing and / or treating diseases such as cancers. # imgabs0 #
Owner:SHANGHAI JIAOTONG UNIV +1

Double-stranded oligonucleotide for inhibiting LPA gene expression and application of double-stranded oligonucleotide

The invention provides double-stranded oligonucleotide for inhibiting LPA gene expression and application of the double-stranded oligonucleotide, and relates to the technical field of nucleic acid drugs. The double-stranded oligonucleotide comprises a positive-sense strand and an antisense strand, wherein the positive-sense strand comprises a nucleotide sequence which is the same as or basically the same as at least 15 continuous nucleotides in the sequence as shown in SEQ ID NO.1, and the antisense strand comprises at least 17 nucleotides and is complementary or basically complementary with the positive-sense strand to form a duplex region; each nucleotide of the double-stranded oligonucleotide is independently selected from an unmodified or modified nucleotide. The double-stranded oligonucleotide can inhibit LPA gene expression and can treat siRNA drugs of diseases related to LPA gene expression, such as cardiovascular and cerebrovascular diseases.
Owner:RIGERNA THERAPEUTICS (SUZHOU) CO LTD

Hydroxamic acid double-target compound derivative and application thereof

The invention discloses a hydroxamic acid double-target compound derivative and application thereof. The double-target derivative designed by the invention has obvious inhibitory activity on WDR5 protein and HDAC protein, can be used as a WDR5 and HDAC double-target inhibitor, is used for treating diseases related to WDR5 and HDAC, and aims at improving the treatment effect of the existing HDAC inhibitor. The micromolecule shows good activity in various experiments, and is expected to be developed into a specific antitumor drug.
Owner:CHINA PHARM UNIV

Agaric polypeptide VR5 with alpha-glucosidase inhibitory activity as well as preparation method and application thereof

The invention discloses an agaric polypeptide VR5 with alpha-glucosidase inhibitory activity and a preparation method and application thereof, and belongs to the technical field of small molecule peptides. The amino acid sequence of the auricularia auricula polypeptide VR5 is VGMLR, and the auricularia auricula polypeptide VR5 can be prepared by a solid-phase synthesis method and an enzymolysis method (flavourzyme). The agaric polypeptide VR5 has the beneficial effects that experiments prove that the agaric polypeptide VR5 has very high alpha-glucosidase inhibitory activity, IC50 is equal to 34.96 mu g / mL, the agaric polypeptide VR5 can be used as an alpha-glucosidase inhibitor for preventing or treating alpha-glucosidase mediated diseases, and the agaric polypeptide VR5 can be used for preventing or treating alpha-glucosidase mediated diseases. Or as a hypoglycemic active component, the composition is added into auxiliary hypoglycemic functional food for auxiliary regulation of the blood sugar level of hyperglycemia people.
Owner:LUDONG UNIVERSITY

Kyllinga brevifolia formula for preventing and treating EV71 type infection

The invention discloses a formula of kyllinga breviscapus for preventing and treating EV71 type infection, and relates to the technical field of medicines, and the formula comprises the following steps: S1, taking kyllinga breviscapus, and adding 6 times of volume of water into the kyllinga breviscapus; s2, decocting for three times, and decocting for 1 hour each time; s3, filtering the decoction, and merging the filtrate; and S4, carrying out reduced pressure concentration at-80 DEG C (the vacuum degree is-0.090 to-0.1 MPa) to obtain freeze-dried powder. Compared with the prior art, the application has the advantages that the enterovirus 71 is a microRNA viridae enterovirus group A member EV71, the kyllinga breviscapus has good inhibitory activity on the enterovirus 71, and the kyllinga breviscapus has important clinical application value on treatment of diseases infected with the enterovirus 71.
Owner:BEIJING UNIV OF CHEM TECH

Pyrimidine compound as well as preparation method, pharmaceutical composition and application thereof

The invention discloses a pyrimidine compound as well as a preparation method, a pharmaceutical composition and application thereof. The structure of the compound is shown in a formula I, and the compound further comprises enantiomers, diastereoisomers, racemes, cis-trans-isomers, deuterated compounds, metabolites, prodrugs, solvates, hydrates, pharmaceutically acceptable salts or co-crystals of the compound. The compound has high-efficiency and high-selectivity inhibitory activity on various mutants of EGFR single mutation, double mutation and triple mutation, has low activity and low toxicity on wild type EGFR, and has a good treatment effect on cancers; the problems that an existing EGFR inhibitor is poor in effect, low in selectivity, resistant to drugs and the like are solved. # imgabs0 #
Owner:CHINA PHARM UNIV

8-site hydroxyurolithin A derivative as well as preparation method and application thereof

The invention belongs to the field of medicinal chemistry, and particularly relates to an 8-position hydroxyurolithin A derivative as well as a preparation method and application thereof. According to the method, 2-bromo-5-(benzyl methoxy)-benzoic acid is prepared from 2-bromo-5-hydroxybenzoic acid through hydroxyl protection, then cyclization, etherification and deprotection reaction are carried out, the reaction conditions are milder, the reaction time is shorter, the yield is higher, groups sensitive to acid and alkali and various substrates can well tolerate the reaction conditions, and the method is suitable for industrial production. The 8-site hydroxyurolithin A derivative is prepared, the obtained derivative is targeted to PDE2 small molecules, and the 8-site hydroxyurolithin A derivative has huge potential for treating neurodegenerative diseases such as Alzheimer's disease.
Owner:CHANGZHOU UNIV

PD-L1 targeting small molecule polypeptide and application thereof

The invention belongs to the technical field of biology, and particularly relates to a PD-L1 targeting micromolecule polypeptide and application thereof. On the basis of machine learning and virtual screening technologies, a series of PD-L1 targeting micromolecule polypeptides are screened out, the in-vivo and in-vitro biological activities of the polypeptides are measured, it is found that the micromolecule polypeptides have the capacity of inducing PD-L1 to form dimerization and good anti-tumor activity, and the anti-tumor activity of the polypeptides is superior to that of PD-L1 monoclonal antibodies and compound inhibitors. Meanwhile, the PD-L1 targeting small-molecule polypeptide has no obvious toxicity, has certain safety, and can be developed into a novel small-molecule polypeptide PD-L1 inhibitor drug.
Owner:OCEAN UNIV OF CHINA

Application of compound as urea channel inhibitor

The invention belongs to the technical field of medicine research and development, and particularly relates to application of a compound as a urea channel inhibitor. The invention provides a compound for inhibiting a urea channel UT-A2 as shown in formula (I), the compound can significantly inhibit rapid transfer of UT-A2 to urea, is ineffective to UT-A3 and UT-B, is a UT-A2 inhibitor small molecule which is found for the first time and has excellent inhibitory activity and high selectivity, has potential to be developed into a novel diuretic drug targeting UT-A2, and has broad application prospects. The traditional Chinese medicine composition is used for clinically treating malnutrition edema caused by low-protein diet, hepatic lesion and the like.
Owner:SHANDONG UNIV

Active peptide with whitening effect as well as preparation method and application thereof

The invention discloses an active peptide with a whitening effect as well as a preparation method and application thereof, and belongs to the technical field of biological medicines and cosmetics. The amino acid sequence of the active peptide is shown as SEQ ID No.1-26, the active peptide has a good inhibition effect on melanin synthesis and tyrosinase activity, and the active peptide has whitening activity and application potential as a whitening product, has the advantages of being safe, effective, free of toxic and side effects, good in biocompatibility and the like, and has a wide application prospect.
Owner:GUANGZHOU JIDA GENE PHARMACY ENG RES CENT CO LTD